Creating hope through breakthrough new cancer medicines

Quiet Therapeutics is a cancer drug discovery company engaged in the discovery and development of novel immuno-oncology and targeted anti-cancer medicines based on the combination of DNA, RNA, or small molecule drugs with our proprietary technology.

Our Platform

Welcome to our Quiet revolution

Quiet’s mission is to create revolutionary cancer therapies by unlocking the maximum potential of anti-cancer and immuno-modulatory agents in the tumor microenvironment while minimizing systemic effects.

Our Platform

We are developing a diverse set of DNA, RNA, and small molecule anti-cancer therapeutics.

Enabling this platform is our proprietary GAGomer technology, which provides for targeted delivery to tumor cells and for cellular internalization.

Quiet is leveraging this specific delivery into tumor cells to pioneer new medicines through the induction of tumor-specific immune responses or by turning cancer cells into factories that produce the agents of their own destruction.




Cohen, Z. R. et al. (2015). Localized RNAi Therapeutics of Chemoresistant Grade IV GliomaUsing Hyaluronan-Grafted Lipid-Based Nanoparticles. ACS Nano (9): 1581-1591

read more



Quiet Therapeutics wins Wow Competition at IATI Biomed 2015 for the most innovative Pharma start-up.

read more



Be Quiet.  A great team can achieve great dreams.  Making a difference is as exciting as it is rewarding.

join us